Tradelink 2020 Interim Report

16 Tradelink Electronic Commerce Limited  Interim Report 2020 Disclosure of Directors’ Interests (Continued) 董事的權益披露 （續） 二零一四年購股權計劃之目的如下： (a) 協助本公司吸引及留聘最佳員工；及 (b) 為僱員、董事、專業顧問、業務夥伴及諮詢顧問 提供額外獎勵，以促進本集團成功； 此計劃將透過授出購股權要約為上述人士提供以個人身 份持有本公司權益的機會。二零一四年購股權計劃所涉 股份在本質上與本公司其他股份相同。 根據二零一四年購股權計劃將予授出的所有購股權予以 行使時可予發行的購股權總數，合共不得超過本公司於 採納日期（即二零一四年五月九日）的已發行股本 10% （即 79,207,319 股股份）（「計劃授權限額」）。在計算計劃授權 限額時，已失效的購股權不得計算在內。計劃授權限額 可於本公司股東大會上取得股東批准後更新，惟按更新 後的計劃授權限額，根據二零一四年購股權計劃將予授 出的所有購股權予以行使時可予發行的該股份總數，不 得超過批准該限額當日已發行股份的 10% （「經更新限 額」）。就計算經更新限額而言，以往授出的購股權（包括 尚未行使、已註銷、失效或行使者）不得計算在內。 因行使購股權而須就每份購股權支付的認購款項將由董 事會釐定，且不得少於下列較高者： (i) 於購股權的書面要約日期（「授出日期」，必須為營 業日），股份於香港聯交所每日報價表所列的收市 價；及 (ii) 緊接授出日期前五個營業日，股份於香港聯交所 每日報價表所列在香港聯交所的平均收市價。 於二零一五年五月八日舉行的本公司股東周年大會上， 股東批准修訂二零一四年購股權計劃第 10.1(D) 、 10.1(E) 及 2.1 條條款。該等二零一四年購股權計劃的修訂授權董 事會酌情豁免或延長 90 日限制，並規定任何豁免或延期 的相應條件以及計劃期間內所授各份購股權適用的行使 期。此舉可讓董事會以符合本公司最佳利益的方式靈活 處理二零一四年購股權計劃十年有效期間可能發生的各 類情況。 於二零二零年三月二十四日舉行的會議上，董事會批准 根據經修訂二零一四年購股權計劃向若干個別人士（「承 授人」）配發購股權，使彼等可以每股港幣 1.09 元認購合 共 7,900,000 股本公司普通股，有關條款與經修訂二零 一四年購股權計劃訂明者相同。承授人可根據各份購股 權要約函件的條件行使購股權。歸屬條件詳情及獲授購 股權詳情載於「未經審核中期財務報告附註」內 附註 18 。 The purpose of the Share Option Scheme 2014 is: (a) to assist the Company to attract and retain the best available personnel; and (b) to provide additional incentives to employees, directors, consultants, business associates and advisers to promote the success of the Group; by providing them with an opportunity to have a personal stake in the Company through an offer of grant of options. The Shares subject to the Share Option Scheme 2014 will be identical in nature with the other Shares of the Company. The total number of share options which may be issued upon exercise of all options to be granted under the Share Option Scheme 2014 shall not exceed in aggregate 10% of the issued capital of the Company at its adoption date, being 79,207,319 shares on 9 May 2014 (the “Scheme Mandate Limit”). Options that have lapsed shall not be counted for the purpose of calculating the Scheme Mandate Limit. The Scheme Mandate Limit may be renewed by obtaining approval of shareholders in general meetings of the Company provided that such total number of shares which may be issued upon exercise of all options to be granted under the Share Option Scheme 2014 under the Scheme Mandate Limit as renewed shall not exceed 10% of the shares issued at the date of approval of such limit (the “Refreshed Limit”). Options previously granted (including those outstanding, cancelled, lapsed or exercised) shall not be counted for the purpose of calculating the Refreshed Limit. The subscription amount payable in respect of each share option upon exercise of an option shall be determined by the Board and shall be not less than the greater of: (i) the closing price of the shares on the SEHK’s daily quotation sheet on the date, which must be a business day, of a written offer of such option (the “Date of Grant”); and (ii) the average closing price of the shares on the SEHK as stated in the SEHK’s daily quotation sheets for the five business days immediately preceding the Date of Grant. At the annual general meeting of the Company on 8 May 2015, shareholders approved the amendments to clauses 10.1(D), 10.1(E) and 2.1 of the Share Option Scheme 2014. Such amendments to the Share Option Scheme 2014 give the Board a discretion to waive or extend the 90-day Limitation with authority to impose conditions to any such waiver or extension and to provide an appropriate exercise period for each grant of options during the Scheme Period. This provides the Board with necessary flexibility it needs to deal, in the best interest of the Company, with the different types of situations that may arise over the course of the ten-year validity period of the Share Option Scheme 2014. At its meeting on 24 March 2020, the Board approved an allotment of share options under the amended Share Option Scheme 2014 to certain individuals (the “Grantees”) entitling them to subscribe for a total of 7,900,000 ordinary shares of the Company at HK$1.09 per share. The terms are the same as stated in the amended Share Option Scheme 2014. The Grantees may exercise the share options subject to the conditions in the respective option offering letters. The details of the vesting conditions and the particulars of the options granted are set out in Note 18 under the heading “Notes to the Unaudited Interim Financial Report”.